ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.99
-0.25 (-2.44%)
At close: Feb 13, 2026, 4:00 PM EST
10.11
+0.12 (1.20%)
After-hours: Feb 13, 2026, 7:14 PM EST
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $972.92 million as of February 13, 2026. Its market cap has increased by 28.01% in one year.
Market Cap
972.92M
Enterprise Value
693.17M
1-Year Change
28.01%
Ranking
Category
Stock Price
$9.99
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $972.92M, an increase of 31.12%. That is a compound annual growth rate of 4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 972.92M | 22.13% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.02B |
| Ventyx Biosciences | 1.00B |
| Evommune | 995.22M |
| Theravance Biopharma | 989.63M |
| Palvella Therapeutics | 965.15M |
| Phathom Pharmaceuticals | 941.10M |
| UroGen Pharma | 940.86M |
| SpyGlass Pharma | 940.22M |